Centric Health Corp. (TSE:CRX – Free Report) – Equities researchers at Stifel Canada lowered their Q4 2024 EPS estimates for Centric Health in a research note issued on Tuesday, November 12th. Stifel Canada analyst J. Keywood now forecasts that the company will post earnings of $0.02 per share for the quarter, down from their prior estimate of $0.03. Stifel Canada currently has a “Hold” rating on the stock. Stifel Canada also issued estimates for Centric Health’s FY2025 earnings at $0.10 EPS.
Separately, Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a report on Thursday, August 8th.
Centric Health Stock Performance
Read More
- Five stocks we like better than Centric Health
- Golden Cross Stocks: Pattern, Examples and Charts
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Stock Splits, Do They Really Impact Investors?
- Tariff Troubles: 3 Stocks Planning Higher Prices
- The 3 Best Fintech Stocks to Buy Now
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
